These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 16400741

  • 1. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial.
    Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741
    [Abstract] [Full Text] [Related]

  • 2. Pemetrexed: a multitargeted antifolate.
    Rollins KD, Lindley C.
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [Abstract] [Full Text] [Related]

  • 3. Pemetrexed in malignant pleural mesothelioma.
    Hazarika M, White RM, Booth BP, Wang YC, Ham DY, Liang CY, Rahman A, Gobburu JV, Li N, Sridhara R, Morse DE, Lostritto R, Garvey P, Johnson JR, Pazdur R.
    Clin Cancer Res; 2005 Feb 01; 11(3):982-92. PubMed ID: 15709163
    [Abstract] [Full Text] [Related]

  • 4. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
    Dickgreber NJ, Fink TH, Latz JE, Hossain AM, Musib LC, Thomas M.
    Clin Cancer Res; 2009 Jan 01; 15(1):382-9. PubMed ID: 19118069
    [Abstract] [Full Text] [Related]

  • 5. FDA drug approval summaries: pemetrexed (Alimta).
    Hazarika M, White RM, Johnson JR, Pazdur R.
    Oncologist; 2004 Jan 01; 9(5):482-8. PubMed ID: 15477632
    [Abstract] [Full Text] [Related]

  • 6. [Pemetrexed].
    Sudoh J, Gemma A.
    Gan To Kagaku Ryoho; 2008 Jun 01; 35(6):1033-8. PubMed ID: 18633241
    [Abstract] [Full Text] [Related]

  • 7. [Update of pemetrexed in thoracic oncology].
    Brechot JM, Morère JF.
    Bull Cancer; 2007 Jun 01; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
    [Abstract] [Full Text] [Related]

  • 8. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb 01; 14(75):16-8. PubMed ID: 15751170
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
    Scagliotti GV, Shin DM, Kindler HL, Vasconcelles MJ, Keppler U, Manegold C, Burris H, Gatzemeier U, Blatter J, Symanowski JT, Rusthoven JJ.
    J Clin Oncol; 2003 Apr 15; 21(8):1556-61. PubMed ID: 12697881
    [Abstract] [Full Text] [Related]

  • 10. Second-line treatment for malignant pleural mesothelioma.
    Ceresoli GL, Zucali PA, Gianoncelli L, Lorenzi E, Santoro A.
    Cancer Treat Rev; 2010 Feb 15; 36(1):24-32. PubMed ID: 19879055
    [Abstract] [Full Text] [Related]

  • 11. Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
    Obasaju CK, Ye Z, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Monberg MJ, Jänne PA, Pemetrexed Expanded Access Program Investigators.
    Lung Cancer; 2007 Feb 15; 55(2):187-94. PubMed ID: 17092602
    [Abstract] [Full Text] [Related]

  • 12. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
    Jänne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Taylor L, Ashland J, Ye Z, Monberg MJ, Obasaju CK.
    Clin Lung Cancer; 2005 Jul 15; 7(1):40-6. PubMed ID: 16098243
    [Abstract] [Full Text] [Related]

  • 13. Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancer.
    Bosch-Barrera J, Gaztañaga M, Ceballos J, Pérez-Gracia JL, López-Picazo JM, García-Foncillas J, Ferrer M, Sanz ML, Pretel M, Idoate MA, Gil-Bazo I.
    Onkologie; 2009 Oct 15; 32(10):580-4. PubMed ID: 19816075
    [Abstract] [Full Text] [Related]

  • 14. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
    Prescrire Int; 2009 Jun 15; 18(101):114. PubMed ID: 19637425
    [No Abstract] [Full Text] [Related]

  • 15. Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.
    Budde LS, Hanna NH.
    Expert Rev Anticancer Ther; 2004 Jun 15; 4(3):361-8. PubMed ID: 15161435
    [Abstract] [Full Text] [Related]

  • 16. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.
    Jassem J, Ramlau R, Santoro A, Schuette W, Chemaissani A, Hong S, Blatter J, Adachi S, Hanauske A, Manegold C.
    J Clin Oncol; 2008 Apr 01; 26(10):1698-704. PubMed ID: 18375898
    [Abstract] [Full Text] [Related]

  • 17. A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer.
    Kotsakis A, Agelaki S, Vardakis N, Stathopoulos G, Vamvakas L, Kalykaki A, Kentepozidis N, Kontopodis E, Sfakiotaki G, Mavroudis D, Georgoulias V.
    Cancer Chemother Pharmacol; 2011 Aug 01; 68(2):415-22. PubMed ID: 21069335
    [Abstract] [Full Text] [Related]

  • 18. Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.
    Zhang YF, Chen ZW, Lu S.
    Chin Med J (Engl); 2009 Oct 20; 122(20):2472-6. PubMed ID: 20079162
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
    Nakagawa K, Yamazaki K, Kunitoh H, Hida T, Gemba K, Shinkai T, Ichinose Y, Adachi S, Nambu Y, Saijo N, Fukuoka M.
    Jpn J Clin Oncol; 2008 May 20; 38(5):339-46. PubMed ID: 18434338
    [Abstract] [Full Text] [Related]

  • 20. Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study.
    Sun Y, Wu YL, Zhou CC, Zhang L, Zhang L, Liu XY, Yu SY, Jiang GL, Li K, Qin SK, Ma SL, Han L, Quinlivan M, Orlando M, Zhang XQ.
    Lung Cancer; 2013 Feb 20; 79(2):143-50. PubMed ID: 23182660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.